Atlas Trials

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Clinical trial NCT00963274 · COMPLETED

Trial details

NCT number
NCT00963274
Sponsor
Virginia Commonwealth University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLymphoma
Start date
2010-04-26
Primary completion
2014-07-17
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.